Doctor Ani Nalbandian

Columbia University Irving Medical Centre, New York (United States of America)

Follow

Contributor content

Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy

Presentation

Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources